Cancer
As the prevalence of cancer rises globally, with an estimated 35 million new cases predicted by 2050, researchers are exploring innovative treatment options, such as cancer immunotherapy. This form of treatment harnesses the body's immune system to fight cancer cells, offering increased life expectancy beyond traditional treatments. A
Cancer
A groundbreaking new treatment option for approximately 2,100 people with advanced womb cancer is set to be available following the National Institute for Health and Clinical Excellence's (NICE) recommendation of pembrolizumab (Keytruda) in final draft guidance. This innovative dual approach combines immunotherapy with chemotherapy, harnessing the body&
Cancer
A former Royal Marine, Andy Lee, who was diagnosed with stomach cancer in 2014, is on a mission to complete 12 ultra marathons in a year to raise money for three charities that helped him overcome the disease. Lee, who served for 16 years and lived in Hoylake for 14
Cancer
Research published in the journal Nature Communications by a team of scientists from the University of California Davis has revealed an unexpected discovery in the regulation of human Fas Ligand (FasL) in the context of solid cancer immunotherapy. The study found that humans are more likely to develop cancers than
Cancer
Researchers at Shanghai Jiao Tong University have made significant findings in the field of cancer gene therapy, discovering that circKCNK2 plays a crucial role in osteolytic bone metastasis of renal cell carcinoma (RCC). The study, which was funded by the National Natural Science Foundation of China and the Precision Research
Cancer
Current cancer research has highlighted the limitations of immunotherapy in treating solid tumors, with a minority of patients benefiting from this treatment strategy. A recent study by researchers at the University of California Los Angeles (UCLA) has identified a critical limitation - T cell exhaustion - which prevents effective cancer
Cancer
Researchers from Soochow University have made significant progress in cancer gene therapy, developing a novel mRNA delivery system that achieves nearly 100% organ-specific transfection in various tissues, including pancreas, lymph nodes, brain, and spleen. The system, called ACCOST (Administration Route-commended Concise Organ-selective mRNA Transfection), uses a cyclic disulfide-primed short polyethyleneimine
Cancer
Researchers from Shanghai University have developed a novel metal-free carbon dot nanozyme, known as F-doped CDs (F-CDs) nanozyme, which exhibits a high near-infrared (NIR-II) quantum yield and NIR-I photothermal effect for cancer catalytic immunotherapy. This breakthrough has the potential to revolutionize the treatment of cancer by enhancing the immune response
Cancer
Researchers at Duke University have presented new findings in the field of cancer gene therapy, highlighting the potential of attenuated viruses to mediate cancer in situ vaccination. According to the study, published in the journal Microbiology and Molecular Biology Reviews, the use of viruses like poliovirus has shown promise in
Cancer
Scientists at the University of California, Los Angeles (UCLA) have made a groundbreaking discovery in genetically engineered stem cell research, enabling patients to continuously produce cancer-fighting T cells. This novel therapeutic strategy, as published in Nature Communications, uses stem cells as an "internal factory" to generate tumor-targeting immune
Cancer
Researchers at the University of California, Los Angeles (UCLA), have made a significant discovery in the field of cancer treatment. A new study has demonstrated the effectiveness of tandem cell therapies involving autologous T cells and hematopoietic stem cells engineered to express the NY-ESO-1 TCR for the treatment of solid
Cancer
Researchers from the Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chengdu Medical College, have made significant strides in understanding the role of preoperative neutrophil-to-albumin ratio as a prognostic indicator in advanced gastric cancer undergoing radical gastrectomy. Their study, published in Therapeutics and Clinical Risk Management, aimed to evaluate
